In its XVth edition of the «Best Initiative of the Year», the newspaper Correo farmacéutico recognized the «Contigo» program, developed by Grupo Pulso for Sandoz, a division of Novartis, and with the collaboration of SARDomus, as the best initiative in the Field of pharmaceutical care and health education.

«Contigo» is a program of extra-hospital care that aims to accompany patients treated with growth hormone and their relatives through a training service that contributes to improve adherence to treatment.

Patient support programs (PSPs) have a holistic approach to health and are focused on the patient as an active subject, who through their empowerment through training and information is responsible for their treatment, thus improving their well-being And providing personalized attention.